(Q36749731)

English

Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function

scientific article published on May 1984

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

hypertrophic obstructive cardiomyopathy

0 references

1 reference

based on heuristic

inferred from title

Bruce H. Brundage

4

object named as

Brundage BH

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

author name string

Anderson DM

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Raff GL

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Ports TA

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Parmley WW

5

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Chatterjee K

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

publication date

1 May 1984

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

British Heart Journal

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

51

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

523-529

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481543

29 September 2017

Hypertrophic cardiomyopathy—Therapy with slow channel inhibiting agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481543

29 September 2017

Effects of propranolol on response to exercise in hypertrophic obstructive cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481543

29 September 2017

Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481543

29 September 2017

Treatment of hypertrophic obstructive cardiomyopathy with verapamil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481543

29 September 2017

Long-term medical management of hypertrophic obstructive cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481543

29 September 2017

Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481543

28 June 2018

Improved diastolic function and systolic performance in hypertrophic cardiomyopathy after nifedipine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481543

28 June 2018

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481543

28 June 2018

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481543

28 June 2018

Influence of verapamil therapy on left ventricular performance at rest and during exercise in hypertrophic cardiomyopathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481543

5 September 2018

Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/6539120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/6539120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The reliability of high voltage of the QRS complex as a diagnostic sign of left ventricular hypertrophy in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/6539120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EFFECTS OF BETA ADRENERGIC BLOCKADE ON THE CIRCULATION WITH PARTICULAR REFERENCE TO OBSERVATIONS IN PATIENTS WITH HYPERTROPHIC SUBAORTIC STENOSIS

1 reference

https://pubmed.ncbi.nlm.nih.gov/6539120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

End-systolic pressure/volume ratio: a new index of ventricular contractility

1 reference

https://pubmed.ncbi.nlm.nih.gov/6539120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of verapamil on left ventricular isovolumic relaxation time and regional left ventricular filling in hypertrophic cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/6539120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/6539120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/6539120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/HRT.51.5.523

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36749731&oldid=1516126349"